Dashboard
Manage Tickers

PYPDPolyPid Ltd.

Nasdaq polypid.com


$ 3.39 $ -0.13 (-3.48 %)    

Friday, 13-Sep-2024 11:21:13 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 474.86 $ 2.12 (0.45 %)
DIA $ 414.87 $ 2.97 (0.72 %)
SPY $ 561.82 $ 2.92 (0.52 %)
TLT $ 100.40 $ 0.27 (0.27 %)
GLD $ 238.66 $ 2.35 (0.99 %)
$ 3.465
$ 3.39
-- x --
-- x --
$ 3.39 - $ 3.39
$ 2.95 - $ 9.20
5,878
na
2.29M
$ 9.66
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

polypid-files-for-resale-of-up-to-39m-ordinary-shares-by-selling-shareholders
PolyPid Files For Resale Of Up To 3.9M Ord...
08/30/2024 20:04:05

- SEC Filing

hc-wainwright--co-reiterates-buy-on-polypid-maintains-14-price-target
HC Wainwright & Co. Reiterates Buy on Poly...
08/15/2024 10:50:14

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates PolyPid (NASDAQ:PYPD) with a Buy and maintains $14 price target.

polypid-q2-2024-gaap-eps-125-misses-118-estimate
PolyPid Q2 2024 GAAP EPS $(1.25) Misses $(...
08/14/2024 11:02:44

PolyPid (NASDAQ:PYPD) reported quarterly losses of $(1.25) per share which missed the analyst consensus estimate of $(1.18) by ...

reported-earlier-polypid-secures-up-to-14m-in-private-placement-to-extend-cash-runway-to-q2-2025
Reported Earlier, PolyPid Secures Up To $1...
08/02/2024 07:06:07

Funding Extends Company's Cash Runway into Second Quarter 2025, which is beyond the Anticipated Timing for SHIELD II Top-...

why-bank-of-marin-bancorp-shares-are-trading-lower-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Bank of Marin Bancorp Shares Are Tradi...
07/29/2024 17:19:13

polypid-files-for-ordinary-shares-offering-of-up-to-200m
Polypid Files For Ordinary Shares Offering...
07/02/2024 20:09:01

-SEC Filing

polypid-updates-on-shield-ii-trial-amidst-kol-insights-on-surgical-site-infection-prevention
PolyPid Updates On SHIELD II Trial Amidst ...
06/18/2024 11:18:56

After a Reduction in Surgical Site Infection (SSI) Rates During COVID, Rates are Now Increasing, Signaling a Return to Pre-CO...

hc-wainwright--co-reiterates-buy-on-polypid-maintains-14-price-target
HC Wainwright & Co. Reiterates Buy on Poly...
06/18/2024 10:16:33

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates PolyPid (NASDAQ:PYPD) with a Buy and maintains $14 price target.

hc-wainwright--co-reiterates-buy-on-polypid-maintains-14-price-target
HC Wainwright & Co. Reiterates Buy on Poly...
05/09/2024 11:23:33

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates PolyPid (NASDAQ:PYPD) with a Buy and maintains $14 price target.

polypid-q1-2024-gaap-eps-137-beats-158-estimate
PolyPid Q1 2024 GAAP EPS $(1.37) Beats $(1...
05/08/2024 11:04:56

PolyPid (NASDAQ:PYPD) reported quarterly losses of $(1.37) per share which beat the analyst consensus estimate of $(1.58) by 13...

hc-wainwright--co-reiterates-buy-on-polypid-maintains-14-price-target
HC Wainwright & Co. Reiterates Buy on Poly...
05/01/2024 10:27:07

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates PolyPid (NASDAQ:PYPD) with a Buy and maintains $14 price target.

polypid-ltd--13g-filing-shows-rosalind-advisors-inc-reported-a-995-stake-in-the-co-as-of-february-13-2024
PolyPid Ltd. 13G Filing Shows Rosalind Ad...
03/01/2024 17:53:00

- SEC Filing

polypid-q4-eps-397-misses-358-estimate
PolyPid Q4 EPS $(3.97) Misses $(3.58) Esti...
02/14/2024 12:11:47

PolyPid (NASDAQ:PYPD) reported quarterly losses of $(3.97) per share which missed the analyst consensus estimate of $(3.58) by ...

earnings-scheduled-for-february-14-2024
Earnings Scheduled For February 14, 2024
02/14/2024 09:48:44

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on r...

polypid-reports-enrollment-of-the-100th-patient-in-ongoing-shield-ii-phase-3-trial
PolyPid Reports Enrollment Of The 100th Pa...
02/12/2024 12:02:56

The Company intends to conduct an unblinded interim analysis once a total of approximately 400 patients complete their 30-day f...

why-applied-therapeutics-shares-are-trading-lower-by-over-35-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Applied Therapeutics Shares Are Tradin...
01/05/2024 18:13:57

Shares of Applied Therapeutics, Inc.

polypid-announces-162m-private-placement-of-3371312-shares-at-481share
PolyPid Announces $16.2M Private Placement...
01/04/2024 21:34:58

The PIPE syndicate is comprised of new and existing investors, including participation from new U.S. life sciences-focused inve...

polypid-q3-eps-340-beats-416-estimate-cash-and-cash-equivalents-and-deposits-of-102m
PolyPid Q3 EPS $(3.40) Beats $(4.16) Estim...
11/08/2023 12:10:21

PolyPid (NASDAQ:PYPD) reported quarterly losses of $(3.40) per share which beat the analyst consensus estimate of $(4.16) by 18...

earnings-scheduled-for-november-8-2023
Earnings Scheduled For November 8, 2023
11/08/2023 09:21:00

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.

polypids-earnings-a-preview
PolyPid's Earnings: A Preview
11/07/2023 20:01:54

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION